Shandong Weigao Group Medical Polymer Performance dei guadagni passati

Il passato criteri di controllo 2/6

Shandong Weigao Group Medical Polymer ha registrato una crescita degli utili a un tasso medio annuo di 4.2%, mentre il settore Medical Equipment ha registrato utili in diminuzione a un tasso medio annuo di 1.1%. I ricavi sono stati in crescita a un tasso medio annuo di 6.4%. Il ritorno sul capitale proprio di Shandong Weigao Group Medical Polymer è 8% e ha margini netti di 14.7%.

Informazioni chiave

4.2%

Tasso di crescita degli utili

4.0%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore	4.3%
Tasso di crescita dei ricavi	6.4%
Rendimento del capitale proprio	8.0%
Margine netto	14.7%
Ultimo aggiornamento sui guadagni	30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Ripartizione dei ricavi e delle spese

Come Shandong Weigao Group Medical Polymer guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

DB:UK2 Ricavi, spese e utili (CNY Millions )
Data	Ricavi	Guadagni	Spese G+A	Spese di R&S
30 Jun 24	12,967	1,912	3,778	600
31 Mar 24	13,098	1,957	3,807	596
31 Dec 23	13,229	2,002	3,837	593
30 Sep 23	13,398	2,221	3,793	597
30 Jun 23	13,566	2,440	3,748	602
31 Mar 23	13,657	2,602	3,721	579
31 Dec 22	13,747	2,764	3,694	556
30 Sep 22	13,903	2,676	3,725	551
30 Jun 22	14,058	2,589	3,755	546
31 Mar 22	13,633	2,432	3,793	525
31 Dec 21	13,209	2,276	3,830	503
30 Sep 21	12,923	2,288	3,865	493
30 Jun 21	12,636	2,300	3,900	484
31 Mar 21	12,129	2,194	3,775	454
31 Dec 20	11,622	2,087	3,651	424
30 Sep 20	11,139	1,998	3,636	403
30 Jun 20	10,656	1,909	3,622	382
31 Mar 20	10,520	1,879	3,699	394
31 Dec 19	10,384	1,850	3,776	406
30 Sep 19	9,993	1,805	3,696	374
30 Jun 19	9,602	1,760	3,615	341
31 Mar 19	9,205	1,616	3,500	326
31 Dec 18	8,809	1,473	3,385	311
30 Jun 18	7,465	1,255	2,842	280
31 Mar 18	6,879	1,255	2,593	277
31 Dec 17	6,293	1,255	2,344	274
30 Jun 17	5,402	1,297	1,918	258
31 Mar 17	5,511	1,165	2,062	262
31 Dec 16	5,620	1,033	2,206	266
30 Sep 16	6,484	1,010	2,469	302
30 Jun 16	6,237	914	2,367	302
31 Mar 16	6,078	1,013	2,153	297
31 Dec 15	5,919	1,113	1,938	293
30 Sep 15	5,878	1,237	1,920	290
30 Jun 15	5,610	1,196	1,839	262
31 Mar 15	5,548	1,161	1,828	252
31 Dec 14	5,278	1,085	1,742	238
30 Sep 14	5,011	307	1,646	222
30 Jun 14	4,996	431	1,583	222
31 Mar 14	4,769	376	1,521	215
31 Dec 13	4,613	388	1,453	209

Guadagni di qualità: UK2 ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di UK2 (14.7%) sono inferiori rispetto allo scorso anno (18%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di UK2 sono cresciuti del 4.2% all'anno negli ultimi 5 anni.

Accelerare la crescita: UK2 ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: UK2 ha avuto una crescita negativa degli utili ( -21.6% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Medical Equipment ( 21% ).

Shandong Weigao Group Medical Polymer Performance dei guadagni passati

Il passato criteri di controllo 2/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

First half 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.27 in 1H 2023)

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.61 in FY 2022)

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.60 in FY 2022)

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

First half 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.34 in 1H 2022)

Recent updates

Shandong Weigao Group Medical Polymer Company Limited Approves the Distribution of Interim Dividend for the Six Months Ended 30 June 2024, Payable on 22 November 2024

Upcoming dividend of CN¥0.092 per share

First half dividend of CN¥0.092 announced

First half 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.27 in 1H 2023)

Shandong Weigao Group Medical Polymer Company Limited Proposes an Interim Dividend for the Six Months Ended 30 June 2024, Payable on Before 22 November 2024

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Shandong Weigao Group Medical Polymer Company Limited Approves Board Appointments

Upcoming dividend of CN¥0.094 per share

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.61 in FY 2022)

Final dividend of CN¥0.094 announced

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, May 28, 2024

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.60 in FY 2022)

Shandong Weigao Group Medical Polymer Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023

Shandong Weigao Group Medical Polymer Company Limited Approves Distribution of Interim Dividend for the Six Months Ended 30 June 2023

Upcoming dividend of CN¥0.073 per share at 2.4% yield

First half 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.34 in 1H 2022)

Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023

New minor risk - Share price stability

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2023 Results on Aug 29, 2023

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2022, Payable on or Before 14 July 2023

Upcoming dividend of CN¥0.079 per share at 1.5% yield

Now 20% undervalued after recent price drop

Full year 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.51 in FY 2021)

Shandong Weigao Group Medical Polymer Company Limited Appoints Li Qiang as an Independent Non-Executive Director

Key Executive recently sold €699k worth of stock

Less than half of directors are independent

Now 24% undervalued

Shandong Weigao Group Medical Polymer Company Limited Announces Resignation of Wang Jinxia as an Independent Non-Executive Director of the Company, A Member of Audit Committee, A Member of Remuneration Committee, A Member of Nomination Committee and A Member of Corporate Governance Committee

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended June 30, 2022, Payable on November 11, 2022

Upcoming dividend of CN¥0.086 per share

Shandong Weigao Group Medical Polymer Company Limited (SEHK:1066) agreed to acquire Weihai Weigao Medical Materials Company Limited from Weigao Holding Company Limited for approximately RMB288.0 million.

First half 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.27 in 1H 2021)

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Changes

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2022 Results on Aug 22, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited Approves Executive Appointments

Upcoming dividend of CN¥0.065 per share

Now 24% undervalued after recent price drop

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: CN¥0.50 (vs CN¥0.47 in FY 2020)

Less than half of directors are independent

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Resignations

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, Jun 06, 2022

Full year 2021 earnings released: EPS: CN¥0.50 (vs CN¥0.45 in FY 2020)

Shandong Weigao Group Medical Polymer Company Limited Recommends Final Dividend for the Year Ended December 31, 2021

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited to Report Q4, 2021 Results on Mar 29, 2022

Upcoming dividend of CN¥0.077 per share

First half 2021 earnings released: EPS CN¥0.27 (vs CN¥0.22 in 1H 2020)

Investor sentiment deteriorated over the past week

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended December 31, 2020 At the Annual General Meeting Held on May 24, 2021

Upcoming dividend of CN¥0.068 per share

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.41 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.41 in FY 2019)

Chairman & Compliance Officer Hua Wei Zhang has left the company

Executive Vice Chairman Yi Wang has left the company

Shandong Weigao Group Medical Polymer Company Limited Approves the Appointment of Tang Zheng Peng as a Non-Executive Director of the Company

New 90-day low: €1.38

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Investor sentiment deteriorated over the past week

Chairman & Compliance Officer recently sold €1.5m worth of stock

Shandong Weigao Group Medical Polymer Company Limited Announces Director Changes

New 90-day low: €1.51